Blake Holly, Chaplin Wendy J, Wainwright Elaine, Taylor Gordon, McNamee Paul, McWilliams Daniel, Abbott-Fleming Victoria, Holmes Jain, Fecowycz Aaron, Walsh David Andrew, Walker-Bone Karen
School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Pain Centre Versus Arthritis, University of Nottingham, Nottingham, United Kingdom.
JMIR Res Protoc. 2023 Oct 30;12:e51474. doi: 10.2196/51474.
Chronic or persistent pain affects one's ability to work or be productive at work, generating high societal and economic burden. However, the provision of work-related advice and support for people with chronic pain is variable or lacking. The Pain-at-Work (PAW) Toolkit was cocreated with people who live with pain, health care professionals, and employers. It aims to increase knowledge about employee rights and how to access support for managing a painful chronic condition in the workplace and provides advice on lifestyle behaviors that facilitate the management of chronic pain.
We aimed to establish the feasibility of conducting a definitive cluster randomized controlled trial comparing access to the PAW Toolkit and telephone support calls from an occupational therapist (PAW) with treatment as usual (ie, standard support from their employer). Our primary outcomes are establishing parameters of feasibility, acceptability, usability, and safety of this digital workplace health intervention. We will assess the candidate primary and secondary outcomes' feasibility and test research processes for a definitive trial.
This is an open-label, parallel 2-arm pragmatic feasibility cluster randomized controlled trial with exploratory health economics analysis and a nested qualitative interview study. We aim to recruit 120 participants from at least 8 workplace clusters (any type, >10 employees) in England. The recruitment of workplaces occurs via personal approach, and the recruitment of individual participants is web based. Eligible participants are vocationally active adults aged ≥18 years with internet access and self-reporting chronic pain interfering with their ability to undertake or enjoy productive work. A restricted 1:1 cluster-level randomization is used to allocate employment settings to PAW or treatment as usual; participants are unblinded to group allocation. Following site- and individual-level consent, participants complete a web-based baseline survey (time 0), including measures of work capacity, health and well-being, and health care resource use. Follow-up is performed at 3 months (time 1) and 6 months (time 2). Feasibility outcomes relate to recruitment; intervention fidelity (eg, delivery, reach, uptake, and engagement); retention; and follow-up. Qualitative evaluation (time 2) is mapped to the Capability, Opportunity, Motivation-Behavior model and will explore intervention acceptability to employees and employers, along with individual and contextual factors influencing the delivery and uptake of the intervention.
Ethics approval was obtained in March 2023. Trial recruitment began in June 2023.
The PAW Toolkit is the first evidence-based digital health intervention aimed at supporting the self-management of chronic or persistent pain at work. This study will inform the design of a definitive trial, including sample size estimation, approaches to cluster site identification, primary and secondary outcomes' selection, and the final health economic model. Findings will inform approaches for the future delivery of this digital health intervention.
ClinicalTrials.gov NCT05838677; https://clinicaltrials.gov/study/NCT05838677.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/51474.
慢性或持续性疼痛会影响一个人的工作能力或工作效率,产生高昂的社会和经济负担。然而,为慢性疼痛患者提供与工作相关的建议和支持的情况参差不齐或有所欠缺。“工作中的疼痛”(PAW)工具包是与疼痛患者、医疗保健专业人员和雇主共同创建的。它旨在增加关于员工权利的知识,以及如何在工作场所获得管理慢性疼痛状况的支持,并提供有助于管理慢性疼痛的生活方式行为建议。
我们旨在确定进行一项确定性整群随机对照试验的可行性,该试验比较使用PAW工具包和职业治疗师的电话支持(PAW)与常规治疗(即雇主提供的标准支持)的效果。我们的主要结局是确定这种数字工作场所健康干预措施在可行性、可接受性、可用性和安全性方面的参数。我们将评估候选主要和次要结局的可行性,并测试确定性试验的研究过程。
这是一项开放标签、平行双臂实用可行性整群随机对照试验,带有探索性卫生经济学分析和嵌套定性访谈研究。我们的目标是从英格兰至少8个工作场所集群(任何类型,员工超过10人)中招募120名参与者。工作场所的招募通过个人方式进行,个体参与者的招募基于网络。符合条件的参与者是年龄≥18岁、有互联网接入且自我报告慢性疼痛干扰其从事或享受高效工作能力的职业活跃成年人。采用受限的1:1整群水平随机化将工作场所分配到PAW组或常规治疗组;参与者对分组分配不设盲。在获得场所和个体层面的同意后,参与者完成基于网络的基线调查(时间0),包括工作能力、健康和幸福感以及医疗保健资源使用情况的测量。在3个月(时间1)和6个月(时间2)进行随访。可行性结局涉及招募;干预保真度(如交付、覆盖范围、采用率和参与度);留存率;以及随访。定性评估(时间2)映射到能力、机会、动机 - 行为模型,将探讨员工和雇主对干预的可接受性,以及影响干预交付和采用的个体和背景因素。
2023年3月获得伦理批准。试验招募于2023年6月开始。
PAW工具包是首个旨在支持工作中慢性或持续性疼痛自我管理的循证数字健康干预措施。本研究将为确定性试验的设计提供信息,包括样本量估计、整群场所识别方法、主要和次要结局的选择以及最终的卫生经济学模型。研究结果将为未来实施这种数字健康干预措施提供方法依据。
ClinicalTrials.gov NCT05838677;https://clinicaltrials.gov/study/NCT05838677。
国际注册报告识别码(IRRID):DERR1 - 10.2196/51474。